BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

China Pharma Completes Third-Party Testing for Dry Eye Therapeutic Device

According to a disclosure by the Shanghai Public Health Clinical Center on June 6, 2023, an epidemiological survey of DED showed that approximately 34...

November 30, 2023 | News

Bahrain Secures Latest Human Genome Sequencing Machine in the Middle East

The Chairman of the Supreme Council of Health, Lt. General Dr. Shaikh Mohammed bin Abdulla Al Khalifa, highlighted the ongoing efforts within the Nati...

November 30, 2023 | News

Merck Expands Newest Biologics Testing Center in Shanghai

Further develops its biosafety testing laboratories to meet local demand New labs complete 2nd phase of company’s € 29 million...

November 30, 2023 | News

Boehringer Ingelheim broadens immuno-oncology portfolio with T3 Pharma acquisition

Despite the significant transformation of the cancer treatment landscape by immunotherapies, long-term remissions only occur in 15-20% of cancer patients. ...

November 27, 2023 | News

Ark Biopharmaceutical's AK0610 gets NMPA IND approval for RSV antibody

This antibody drug is bioengineered based on a neutralizing antibody originally isolated from a recovered child from respiratory syncytial virus (RSV) infe...

November 24, 2023 | News

IASO Bio opens global CAR-T center in China for international MM patients.

As a biopharmaceutical company that engages in the R&D, production and sales of innovative cell drugs, IASO Bio is not only developing CAR-T therapies ...

November 24, 2023 | News

BeiGene and Ensem Therapeutics Partner to Advance CDK2 Inhibitor

“We are committed to developing novel molecules with the potential to transform the therapeutic landscape for cancer patients, and this partnership f...

November 23, 2023 | News

Ark Biopharma's AK0610 Receives NMPA IND Approval for RSV Neutralizing Antibody

It is anticipated to protect infants throughout an entire RSV season. ArkBio licensed the drug's intellectual properties from the Institute of Microb...

November 23, 2023 | News

XtalPi and EDDC Collaborate on Biomedical Innovation with Robotics and Language Models

Building upon an ongoing collaboration that was initiated in December 2022 to utilize artificial intelligence (AI) and automation to develop targ...

November 22, 2023 | News

SK Bioscience and Hilleman Labs Collaborate on Next-Gen Ebola Vaccine

SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company has entere...

November 22, 2023 | News

Porton Advanced and Ascle Therapeutics Form Strategic Partnership for NK Cell Applications in Cancer Prevention, Beauty, and Anti-aging

Porton Advanced is committed to providing end-to-end gene and cell therapy CDMO services, covering fields such as plasmids, cell therapy, gene therapy, and...

November 21, 2023 | News

ASP Japan G.K. Significantly Expands Product Portfolio for Sterilization Monitoring

ASP Japan G.K., a leading company in the field of infection control, announced the introduction of a new product portfolio of sterilization monitoring prod...

November 20, 2023 | News

WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange

WuXi XDC issued a total of 178,446,000 shares under the global offering at an offer price of HK$20.60 per share (being the high-end of the indica...

November 20, 2023 | News

Groundbreaking milestone as the United Kingdom MHRA greenlights CASGEVY™, heralding a new era in CRISPR-based gene editing therapies

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) have shattered scientific barriers today as the United Kingdom Me...

November 17, 2023 | News

Stay Connected